A Qualitative Systematic Literature Review of the Role of U.S. Pharmacists in Prescribing Pre-Exposure Prophylaxis (PrEP)
Abstract
:1. Introduction
2. Methods
2.1. Study Selection, Screening, Inclusion and Exclusion Criteria
2.2. Data Abstraction and Quality Assessment
3. Results
4. Discussion
5. Limitations
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Appendix A. Search Strategies
References
- Center for Disease Control. HIV in the United States and Dependent Areas. Available online: https://www.cdc.gov/hiv/statistics/overview/ataglance.html (accessed on 28 March 2022).
- Center for Disease Control. Statement on FDA Approval of Drug for HIV Prevention. Available online: https://www.cdc.gov/nchhstp/newsroom/2012/fda-approvesdrugstatement.html (accessed on 13 May 2022).
- Food and Drug Administration. Truvada for PrEP. Available online: https://www.fda.gov/media/83586/download (accessed on 31 July 2022).
- Thigpen, M.C.; Kebaabetswe, P.M.; Paxton, L.A.; Smith, D.K.; Rose, C.E.; Segolodi, T.M. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in botswana. N. Engl. J. Med. 2012, 367, 423–434. [Google Scholar] [CrossRef]
- Drabo, E.; Hay, J.; Vardavas, R.; Wagner, Z.; Sood, N. A cost-effectiveness analysis of pre-exposure prophylaxis (PrEP) for the prevention of HIV in the Los Angeles county MSM population. Value Health 2014, 17, A272. [Google Scholar] [CrossRef] [Green Version]
- Amico, K.R.; Bekker, L.-G. Global prep roll-out: Recommendations for programmatic success. Lancet HIV 2019, 6, e137–e140. [Google Scholar] [CrossRef] [PubMed]
- Paltiel, A.D.; Freedberg, K.A.; Scott, C.A.; Schackman, B.R.; Losina, E.; Wang, B. HIV preexposure prophylaxis in the United States: Impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin. Inf. Dis. 2009, 48, 806–815. [Google Scholar] [CrossRef] [Green Version]
- Macapagal, K.; Kraus, A.; Korpak, A.K.; Jozsa, K.; Moskowitz, D.A. Prep awareness, uptake, barriers, and correlates among adolescents assigned male at birth who have sex with males in the us. ArchSexl Behav. 2020, 49, 113–124. [Google Scholar] [CrossRef] [PubMed]
- Goparaju, L.; Praschan, N.C.; Warren-Jeanpiere, L.; Experton, L.S.; Young, M.A.; Kassaye, S. Stigma, partners, providers and costs: Potential barriers to prep uptake among us women. J. AIDS Clin. Res. 2017, 8, 730. [Google Scholar] [CrossRef] [PubMed]
- Bush, S.; Magnuson, D.; Rawlings, M.K.; Hawkins, T.; McCallister, S.; Mera Giler, R. Racial characteristics of ftc/tdf for pre-exposure prophylaxis (PrEP) users in the US. ASM Microbe/ICAAC 2016, 16, 16. [Google Scholar]
- Pinto, R.M.; Berringer, K.R.; Melendez, R.; Mmeje, O. Improving PrEP implementation through multilevel interventions: A synthesis of the literature. AIDS Behav. 2018, 22, 3681–3691. [Google Scholar] [CrossRef] [Green Version]
- Berenbrok, L.A.; Tang, S.; Gabriel, N.; Guo, J.; Sharareh, N.; Patel, N. Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis. J. Am. Pharm. Assoc. 2022, 62, 1816–1822. [Google Scholar] [CrossRef]
- Crawford, N.D.; Josma, D.; Morris, J.; Hopkins, R.; Young, H.N. Pharmacy-based pre-exposure prophylaxis support among pharmacists and Men who have Sex with Men. J. Am. Pharm. Assoc. 2020, 60, 602–608. [Google Scholar] [CrossRef]
- Wilby, K.J.; Smith, A.J. A narrative review of continuing professional development needs for pharmacists with respect to pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV). Pharmacy 2020, 8, 84. [Google Scholar] [CrossRef] [PubMed]
- Zhao, A.; Dangerfield, D.T.; Nunn, A.; Patel, R.; Farley, J.E.; Ugoji, C.C. Pharmacy-based interventions to increase use of HIV pre-exposure prophylaxis in the United States: A scoping review. AIDS Behav. 2022, 26, 1377–1392. [Google Scholar] [CrossRef] [PubMed]
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D. The prisma 2020 statement: An updated guideline for reporting systematic reviews. Syst. Rev. 2021, 10, n71. [Google Scholar] [CrossRef]
- Britten, N.; Campbell, R.; Pope, C.; Donovan, J.; Morgan, M.; Pill, R. Using meta ethnography to synthesise qualitative research: A worked example. J. Health Serv. Res. Policy 2002, 7, 209–215. [Google Scholar] [CrossRef] [PubMed]
- Campbell, R.; Britten, N.; Pound, P.; Donovan, J.; Morgan, M.; Pill, R.; Pope, C. Using meta-ethnography to synthesise qualitative research: Moving beyond effectiveness in evidence synthesis. In Moving Beyond Effectiveness in Evidence Synthesis: Methodological Issues in the Synthesis of Diverse Sources of Evidence; Popay, J., Ed.; National Institute for Health and Clinical Excellence: London, UK, 2006; pp. 75–82. [Google Scholar]
- Lewin, S.; Glenton, C.; Munthe-Kaas, H.; Carlsen, B.; Colvin, C.J.; Gülmezoglu, M. Using qualitative evidence in decision making for health and social interventions: An approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual). PLoS Med. 2015, 12, e1001895. [Google Scholar] [CrossRef] [Green Version]
- Gregg, E.; Linn, C.; Nace, E.; Gelberg, L.; Cowan, B.; Fulcher, J.A. Implementation of HIV preexposure prophylaxis in a homeless primary care setting at the Veterans Affairs. J. Prim. Care Community Health 2020, 11, 2150132720908370. [Google Scholar] [CrossRef] [Green Version]
- Hopkins, R.; Josma, D.; Morris, J.; Klepser, D.G.; Young, H.N.; Crawford, N.D. Support and perceived barriers to implementing pre-exposure prophylaxis screening and dispensing in pharmacies: Examining concordance between pharmacy technicians and pharmacists. J. Am. Pharm. Assoc. 2021, 61, 115–120. [Google Scholar] [CrossRef]
- Koester, K.A.; Saberi, P.; Fuller, S.M.; Arnold, E.A.; Steward, W.T. Attitudes about community pharmacy access to HIV prevention medications in California. J. Am. Pharm. Assoc. 2020, 60, e179–e183. [Google Scholar] [CrossRef]
- Bellman, R.; Mohebbi, S.; Nobahar, N.; Parizher, J.; Apollonio, D.E. An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco bay area pharmacies. J. Am. Pharm. Assoc. 2022, 62, 370–377.e3. [Google Scholar] [CrossRef]
- Tarfa, A.; Pecanac, K.; Shiyanbola, O. Patients, social workers, and pharmacists’ perceptions of barriers to providing HIV care in community pharmacies in the United States. Pharmacy 2021, 9, 178. [Google Scholar] [CrossRef]
- Hattingh, H.L.; Emmerton, L.; Ng Cheong Tin, P.; Green, C. Utilization of community pharmacy space to enhance privacy: A qualitative study. Health Expect. 2016, 19, 1098–1110. [Google Scholar] [CrossRef] [PubMed]
- National Alliance of State Pharmacy Associations, State-by-State Look at Pharmacist CPAs. Available online: https://scpa.memberclicks.net/assets/resources/2020/CPA%20State%20Maps%20-%20Pharmacists%20Authority.pdf (accessed on 5 March 2022).
- Zhu, V.; Tran, D.; Banjo, O.; Onuegbu, R.; Seung, H.; Layson-Wolf, C. Patient perception of community pharmacists prescribing pre-exposure prophylaxis for HIV prevention. J. Am. Pharm. Assoc. 2020, 60, 781–788.e2. [Google Scholar] [CrossRef] [PubMed]
- University of Pittsburgh. 9 Out of 10 Americans Live Close to Community Pharmacy. Available online: https://www.eurekalert.org/news-releases/960126 (accessed on 30 August 2022).
- Cohen, D.A.; Scribner, R.A.; Farley, T.A. A structural model of health behavior: A pragmatic approach to explain and influence health behaviors at the population level. Prev. Med. 2000, 30, 146–154. [Google Scholar] [CrossRef] [PubMed]
Author and Year | Qualitative Study Design: Interview or Focus Group | Framework | Population(s) Sampled | Location (State) | CERQual Grade |
---|---|---|---|---|---|
Crawford et al., 2020 [13] | Interview | N/A | Black MSM and Pharmacists | Georgia | Low |
Gregg et al., 2020 [20] | Focus group | N/A | Multidisciplinary teams | California | Low |
Hopkins et al., 2020 [21] | Interviews | CFIR | Pharmacists and Pharmacy Technicians | Georgia | High |
Koester et al., 2020 [22] | Interviews | N/A | Pharmacists | California | Medium |
Bellman et al., 2022 [23] | Interviews (Mixed methods used) | N/A | Pharmacists | California | Medium |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cernasev, A.; Melton, T.C.; Jasmin, H.; Barenie, R.E. A Qualitative Systematic Literature Review of the Role of U.S. Pharmacists in Prescribing Pre-Exposure Prophylaxis (PrEP). Pharmacy 2023, 11, 9. https://doi.org/10.3390/pharmacy11010009
Cernasev A, Melton TC, Jasmin H, Barenie RE. A Qualitative Systematic Literature Review of the Role of U.S. Pharmacists in Prescribing Pre-Exposure Prophylaxis (PrEP). Pharmacy. 2023; 11(1):9. https://doi.org/10.3390/pharmacy11010009
Chicago/Turabian StyleCernasev, Alina, Tyler C. Melton, Hilary Jasmin, and Rachel E. Barenie. 2023. "A Qualitative Systematic Literature Review of the Role of U.S. Pharmacists in Prescribing Pre-Exposure Prophylaxis (PrEP)" Pharmacy 11, no. 1: 9. https://doi.org/10.3390/pharmacy11010009